Clinical Trials, Consulting
Total Trials
91
As Lead Sponsor
0
As Collaborator
Total Enrollment
28,824
NCT00221026
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2004
Completion: Jun 30, 2006
NCT01336530
Tepilta® Versus Oxetacaine, Antacids and Placebo
Phase: Phase 3
Start: Apr 30, 2011
Completion: Jan 31, 2017
NCT01421966
Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes
Start: Aug 31, 2011
Completion: Oct 31, 2015
NCT01447901
Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Phase: N/A
Start: Sep 30, 2011
Completion: Sep 30, 2012
NCT02065882
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Start: Mar 31, 2013
Completion: Nov 18, 2020
NCT01838499
Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Start: May 31, 2013
Completion: Oct 31, 2014
NCT01986426
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
Phase: Phase 1
Start: Nov 30, 2013
Completion: Aug 31, 2018
NCT01850004
Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
Start: Jan 22, 2014
Completion: Oct 8, 2021
NCT02066467
Maximizing CRT Delivery by Using MultipolAr Coronary Sinus Lead FamiLy ACUITY® X4 - RALLY X4 Study
Start: Feb 28, 2014
Completion: Sep 30, 2016
NCT02232425
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
Start: Sep 30, 2014
NCT02294877
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Completion: Feb 21, 2024
NCT02210221
CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI
Start: Dec 19, 2014
Completion: Mar 31, 2021
NCT02489682
Clinical Informed Consent Format Evaluation
Start: Dec 31, 2014
Completion: May 31, 2015
NCT02518932
The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man
Start: Mar 31, 2015
Completion: Mar 31, 2016
NCT02488239
Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)
Start: May 31, 2015
Completion: Mar 31, 2017
NCT02769780
A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy
Start: Jul 8, 2015
Completion: Aug 9, 2021
NCT02802059
E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
Start: Oct 7, 2015
Completion: Oct 12, 2020
NCT02556177
Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2
Start: Nov 30, 2015
Completion: Jan 31, 2018
NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Completion: Jun 21, 2021
NCT02596854
Comparative Study of Conventional 1.5 and 3.0T MR Images With Synthetically Reconstructed MR Images
Completion: Apr 30, 2016
NCT02725515
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Start: Feb 16, 2016
Completion: Jul 17, 2018
NCT04017325
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
Start: Mar 17, 2016
Completion: Jun 3, 2020
NCT02794168
Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury
Start: Jun 30, 2016
Completion: Jun 30, 2020
NCT02976753
Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products
Start: Dec 31, 2016
Completion: Nov 3, 2021
NCT03046069
FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey
Start: Feb 20, 2017
Completion: Feb 23, 2018
NCT02974881
HighLife™ Transcatheter Mitral Valve Replacement System Study
Start: Jul 20, 2017
Completion: Jan 16, 2024
NCT03153007
Study of Subjects With Diabetic Foot Ulcer (DFU)
Start: Aug 11, 2017
Completion: Dec 6, 2017
NCT03416907
Informed Consent Formats by Information Preference and Priority
Start: Nov 27, 2017
Completion: Dec 31, 2017
NCT03411915
A Study of XmAb®18087 in Subjects With NET and GIST
Start: Jan 22, 2018
Completion: Oct 26, 2021
NCT03758534
Natural History of GACI With or Without ARHR2 or PXE
Start: Mar 15, 2018
Completion: Dec 31, 2019
NCT03102606
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
Start: May 29, 2018
Completion: Feb 8, 2021
NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Start: Jul 10, 2018
Completion: Sep 6, 2022
NCT03680105
A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
Start: Aug 24, 2018
Completion: Jan 15, 2019
NCT04773015
A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in Europe
Start: Dec 11, 2018
Completion: Dec 7, 2021
NCT03830762
Xanamem™ in Healthy Elderly Subjects
Start: Jan 21, 2019
Completion: Jan 7, 2020
NCT03513939
A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation
Phase: Phase 1/2
Start: Feb 7, 2019
Completion: Oct 31, 2028
NCT03870945
Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)
Start: Feb 25, 2019
Completion: May 28, 2024
NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Start: May 1, 2019
Completion: Feb 15, 2024
NCT04029363
Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
Start: May 28, 2019
Completion: Dec 15, 2031
NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
Start: Aug 20, 2019
Completion: Apr 30, 2037
NCT04125810
A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress
Start: Sep 2, 2019
Completion: Feb 7, 2020
NCT04094363
CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems
Start: Oct 3, 2019
Completion: Nov 26, 2019
NCT04120610
FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia
Start: Dec 9, 2019
Completion: Nov 21, 2022
NCT04294654
Vortioxetine in Patients With Depression and Early Dementia
Phase: Phase 4
Start: Feb 28, 2020
Completion: Jul 20, 2022
NCT04393779
Observational Registry on the HARPOON Device
Start: Oct 2, 2020
Completion: Nov 17, 2022
NCT04723602
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Start: Jan 6, 2021
Completion: Dec 14, 2021
NCT04432389
Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture
Start: Jan 8, 2021
Completion: Mar 31, 2024
NCT04620239
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Start: Mar 22, 2021
Completion: Jan 25, 2029
NCT05312567
FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms
Start: Mar 24, 2021
Completion: Jul 31, 2023
NCT04796935
A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control
Start: Apr 4, 2021
Completion: Nov 24, 2021
NCT04590781
Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
Start: May 10, 2021
Completion: Mar 24, 2022
NCT04883333
A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults
Start: May 17, 2021
Completion: Jul 18, 2022
NCT04622007
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)
Start: Jun 2, 2021
Completion: Dec 9, 2024
NCT05107258
A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care
Start: Aug 17, 2021
Completion: Sep 16, 2021
NCT04844866
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Start: Aug 18, 2021
Completion: Jul 31, 2029
NCT04752358
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2)
Start: Sep 15, 2021
Completion: Dec 15, 2023
NCT04646603
MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
Start: Dec 1, 2021
Completion: Jul 1, 2022
NCT04985825
Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Start: Dec 16, 2021
Completion: Aug 17, 2022
NCT05274308
Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples
Start: Feb 7, 2022
Completion: Jul 26, 2022
NCT05832775
Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's
Start: May 31, 2022
Completion: Apr 30, 2023
NCT05429840
Safety & PK of Single Doses of MT1980
Start: Jun 1, 2022
Completion: Oct 4, 2022
NCT06125717
Phase 1 Evaluation of H1 Influenza Vaccine Delivered by MIMIX MAP
Start: Jul 2, 2022
Completion: Mar 13, 2023
NCT05032040
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Start: Jul 21, 2022
Completion: Dec 30, 2025
NCT05599308
Evaluation of Blood Pressure Monitor With AFib Screening Feature
Start: Sep 6, 2022
Completion: Apr 11, 2023
NCT05414123
A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide
Start: Sep 7, 2022
Completion: Oct 13, 2023
NCT05171946
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
Start: Nov 20, 2022
Completion: Jul 1, 2023
NCT05322590
BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
Start: Jan 9, 2023
Completion: Apr 30, 2029
NCT05529472
Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy
Start: Jan 10, 2023
Completion: Oct 10, 2024
NCT05721001
French Registry Conducted on E-vita OPEN NEO
Start: Jan 11, 2023
Completion: Aug 31, 2027
NCT05723692
A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers
Start: Jan 17, 2023
Completion: Oct 27, 2023
NCT05127915
US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism
Start: Jan 27, 2023
Completion: Dec 31, 2026
NCT05743335
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
Start: Mar 7, 2023
Completion: Dec 1, 2023
NCT05891197
A Biomarker Screening Protocol for Participants With Solid Tumors
Start: May 19, 2023
Completion: Feb 5, 2025
NCT05871541
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Start: May 26, 2023
Completion: Mar 25, 2024
NCT05710692
Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease
Phase: Phase 2/3
Start: Aug 1, 2023
Completion: Mar 31, 2028
NCT05979207
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
Completion: Oct 30, 2023
NCT05361486
Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru
Start: Aug 28, 2023
Completion: Oct 31, 2024
NCT05693909
A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes
Start: Sep 4, 2023
Completion: May 31, 2028
NCT05997264
Anthrax AV7909 Boost Evaluation Study
Start: Dec 5, 2023
Completion: Aug 31, 2026
NCT06252753
Observational Study Protocol: LIVER-R
Start: Dec 20, 2023
Completion: Dec 30, 2030
NCT06401213
A First-in-Human Safety Trial of MTX-463
Start: Apr 15, 2024
Completion: Nov 15, 2024
NCT06385509
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
Start: May 10, 2024
Completion: Mar 31, 2026
NCT06465810
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Start: Jun 25, 2024
Completion: Dec 29, 2031
NCT06560151
BARDA BP-I-23-001 H5 Influenza
Start: Aug 21, 2024
Completion: Jun 11, 2025
NCT06716606
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Start: Dec 12, 2024
Completion: Jan 8, 2030
NCT07076030
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Start: Apr 15, 2025
Completion: Dec 31, 2025
NCT06941025
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Start: Jun 30, 2025
Completion: Dec 31, 2034
NCT06328608
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Start: Jul 29, 2025
Completion: Apr 30, 2031
NCT07059000
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Start: Aug 13, 2025
NCT07199569
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Start: Oct 31, 2025
Completion: Oct 31, 2026
NCT07205666
The Eplontersen Pregnancy and Lactation Outcomes Study
Start: Nov 30, 2025
Completion: Dec 30, 2035
Loading map...